Of the top five KDs detected in relation to the T2DM subnetwork, two KDs (IRS1 and IGF1R) are known regulators for T2DM, so they have served as effective drug targets according to the DrugBank database [64]. This evidence concerns the gene IRS1 and type 2 diabetes mellitus.